Stockreport

Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage drug platform company developing nov [Read more]